Journal of Hepatology
Volume 42, Issue 1 , Pages 61-67 , January 2005

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

  • Diego Piccioli

      Affiliations

    • Immunology and Virology Department, Chiron Vaccines Research Center, via Fiorentina 1, 53100 Siena, Italy
  • ,
  • Simona Tavarini

      Affiliations

    • Immunology and Virology Department, Chiron Vaccines Research Center, via Fiorentina 1, 53100 Siena, Italy
  • ,
  • Sandra Nuti

      Affiliations

    • Immunology and Virology Department, Chiron Vaccines Research Center, via Fiorentina 1, 53100 Siena, Italy
  • ,
  • Piero Colombatto

      Affiliations

    • Gastroenterology and Hepatology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
  • ,
  • Maurizia Brunetto

      Affiliations

    • Gastroenterology and Hepatology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
  • ,
  • Ferruccio Bonino

      Affiliations

    • Gastroenterology and Hepatology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
  • ,
  • Pietro Ciccorossi

      Affiliations

    • Gastroenterology and Hepatology Unit, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy
  • ,
  • Francesca Zorat

      Affiliations

    • Institute of Internal Medicine, School of Medicine, University of Trieste, Trieste, Italy
  • ,
  • Gabriele Pozzato

      Affiliations

    • Institute of Internal Medicine, School of Medicine, University of Trieste, Trieste, Italy
  • ,
  • Consuelo Comar

      Affiliations

    • Institute of Internal Medicine, School of Medicine, University of Trieste, Trieste, Italy
  • ,
  • Sergio Abrignani

      Affiliations

    • Immunology and Virology Department, Chiron Vaccines Research Center, via Fiorentina 1, 53100 Siena, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 577 243032; fax: +39 577 243564.
  • ,
  • Andreas Wack

      Affiliations

    • Immunology and Virology Department, Chiron Vaccines Research Center, via Fiorentina 1, 53100 Siena, Italy

Received 20 July 2004 ,Revised 14 September 2004 ,Accepted 21 September 2004.

References 

  1. Gordon S. Pattern recognition receptors: doubling up for the innate immune response. Cell. 2002;111:927–930
  2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, et al. Immunobiology of dendritic cells. Annu Rev Immunol. 2000;18:767–811
  3. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2002;2:151–161
  4. Randolph GJ, Beaulieu S, Lebecque S, Steinman RM, Muller WA. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science. 1998;282:480–483
  5. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994;179:1109–1118
  6. Liu YJ, Kanzler H, Soumelis V, Gilliet M. Dendritic cell lineage, plasticity and cross-regulation. Nat Immunol. 2001;2:585–589
  7. Houghton M. Hepatitis C viruses. In:  Fields BN,  Knipe DM,  Howley PM editor. Virology. Philadelphia, PA: Lippincott; 1996;p. 1035–1058
  8. Racanelli V, Rehermann B. Hepatitis C virus infection: when silence is deception. Trends Immunol. 2003;24:456–464
  9. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288:339–344
  10. Erickson AL, Kimura Y, Igarashi S, Eichelberger J, Houghton M, Sidney J, et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. Immunity. 2001;15:883–895
  11. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med. 2002;195:35–41
  12. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med. 2002;195:43–49
  13. Lechner F, Wong DK, Dunbar PR, Chapman R, Chung RT, Dohrenwend P, et al. Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000;191:1499–1512
  14. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194:1395–1406
  15. Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, et al. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol. 2002;169:3447–3458
  16. Longman RS, Talal AH, Jacobson IM, Albert ML, Rice CM. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood. 2004;103:1026–1029
  17. Dolganiuc A, Kodys K, Kopasz A, Marshall C, Do T, Romics LJ, et al. Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. J Immunol. 2003;170:5615–5624
  18. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood. 2001;97:3171–3176
  19. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C virus infection. Gastroenterology. 2001;120:512–524
  20. Kanto T, Hayashi N, Takehara T, Tatsumi T, Kuzushita N, Ito A, et al. Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J Immunol. 1999;162:5584–5591
  21. Sarobe P, Lasarte JJ, Casares N, Lopez-Diaz de Cerio A, Baixeras E, Labarga P, et al. Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus Core and E1 proteins. J Virol. 2002;76:5062–5070
  22. Meier V, Mihm S, Braun Wietzke P, Ramadori G. HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?. World J Gastroenterol. 2001;7:228–234
  23. Boisvert J, He XS, Cheung R, Keeffe EB, Wright T, Greenberg HB. Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis. 2001;184:827–835
  24. Gong GZ, Lai LY, Jiang YF, He Y, Su XS. HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol. 2003;9:291–294
  25. Kakumu S, Ito S, Ishikawa T, Mita Y, Tagaya T, Fukuzawa Y, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol. 2000;15:431–436
  26. Abrignani S. Immune responses throughout hepatitis C virus (HCV) infection: HCV from the immune system point of view. Springer Semin Immunopathol. 1997;19:47–55
  27. Anthony DD, Yonkers NL, Post AB, Asaad R, Heinzel FP, Lederman MM, et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol. 2004;172:4907–4916
  28. Goutagny N, Vieux C, Decullier E, Ligeoix B, Epstein A, Trepo C, et al. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection. J Infect Dis. 2004;189:1646–1655
  29. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, et al. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med. 2001;194:1823–1834
  30. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med. 1994;45:491–503
  31. Biron CA. Interferons alpha and beta as immune regulators—a new look. Immunity. 2001;14:661–664

PII: S0168-8278(04)00454-4

doi: 10.1016/j.jhep.2004.09.014

Journal of Hepatology
Volume 42, Issue 1 , Pages 61-67 , January 2005